Co-development of rhCollagen-based dermal and soft tissue filler products with AbbVie is advancing according to plan Launch of large animal study for Company's 3D bioprinted regenerative breast implant program is on track for Q2 2022Initiate development of a 3D bioprinted tissue model of the human intestine to support drug discovery and personalized medicine for inflammatory bowel diseases in Q3 2022 Reports strong balance sheet with cash and cash equivalents of $41M as of March 31, 2022REHOVOT, …
